News
AstraZeneca, Boehringer and GSK are enacting these caps. A price cap will make asthma inhalers more accessible to uninsured and underinsured patients. These caps will take effect on June 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback